Prof. Dr. Andreas Trumpp is head of the Division of Stem Cells and Cancer (DKFZ) and Managing Director of the Heidelberg Institute for Stem Cell Technology and Experimental Medicine. He and his team is interested in unraveling the molecular and cellular basis of hematopoietic stem cell (HSC) and embryonic stem cell (ESC) self-renewal. With that the team wants to develop strategies to detect and target cancer and metastatic stem cells and break therapy resistance. http://www.ie-freiburg.mpg.de/events/10546/4678708
[more]
